MicroRNA-200a Downregulation in Human Glioma Leads to Gαi1 Over-expression, Akt Activation, and Cell Proliferation

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2018 Mar 10

PMID 29520106

Citations 70

Authors

Yuan-Yuan Liu

Min-Bin Chen

Long Cheng

Zhi-Qing Zhang

Zheng-Quan Yu

Qin Jiang

Gang Chen

Cong Cao

Affiliations

Soon will be listed here.

Abstract

We previously identified a pivotal role for G protein α inhibitory subunit 1 (Gαi1) in mediating PI3K-Akt signaling by receptor tyrosine kinases (RTKs). Here, we examined the expression and biological function of Gαi1 in human glioma. Gαi1 mRNA and protein expression were significantly upregulated in human glioma tissues, which correlated with downregulation of an anti-Gαi1 miRNA: microRNA-200a ("miR-200a"). Forced-expression of miR-200a in established (A172/U251MG lines) and primary (patient-derived) human glioma cells resulted in Gαi1 downregulation, Akt inactivation and proliferation inhibition. Reduction of Gαi1 expression by shRNA, dominant negative mutant interference, or complete Gαi1 depletion inhibited Akt activation and cell proliferation. Notably, miR-200a was unable to inhibit glioma cell proliferation when Gαi1 was silenced or mutated. Co-immunoprecipitation studies, in human glioma cells and tissues, show that Gαi1 forms a complex with multiple RTKs (EGFR, PDGFRα, and FGFR) and the adapter protein Gab1. In vivo, the growth of subcutaneous and orthotopic glioma xenografts in nude mice was largely inhibited by expression of Gαi1 shRNA or miRNA-200a. Collectively, miR-200a downregulation in human glioma leads to Gαi1 over-expression, Akt activation and glioma cell proliferation.

Citing Articles

miR-200 family as new potential prognostic factor of overall survival of patients with WHO G2 and WHO G3 brain gliomas.

Bilski M, Ciesielka M, Orzechowska M, Jarosz B, Calka P, Bilska S Sci Rep. 2024; 14(1):29345.

PMID: 39592656 PMC: 11599569. DOI: 10.1038/s41598-024-80656-z.

COL8A1 overexpression promotes glioma cell growth by activating focal adhesion kinase signaling cascade.

Qian J, Xing H, Wang Y, Li C, Chen H, Rong J NPJ Precis Oncol. 2024; 8(1):273.

PMID: 39578589 PMC: 11584746. DOI: 10.1038/s41698-024-00762-z.

Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer.

Jiang J, Qiao Y, Zhu X, Gu Q, Lu J, Ye Z Cell Death Dis. 2024; 15(9):699.

PMID: 39349432 PMC: 11442978. DOI: 10.1038/s41419-024-07079-6.

The critical role of Gαi3 in oral squamous cell carcinoma cell growth.

Li Q, Huang Z, Li Z, Fan J, Li K Cell Death Discov. 2024; 10(1):420.

PMID: 39349425 PMC: 11443079. DOI: 10.1038/s41420-024-02191-0.

Origin recognition complex 6 overexpression promotes growth of glioma cells.

Yang W, Zhang W, Wang Y, Lou Y, Cai Y, Zhu J Cell Death Dis. 2024; 15(7):485.

PMID: 38971772 PMC: 11227543. DOI: 10.1038/s41419-024-06764-w.

References

Westphal M, Lamszus K . The neurobiology of gliomas: from cell biology to the development of therapeutic approaches. Nat Rev Neurosci. 2011; 12(9):495-508. DOI: 10.1038/nrn3060. View

Fan J, Ruan J, Liu W, Zhu L, Zhu X, Yi H . miR-135b expression downregulates Ppm1e to activate AMPK signaling and protect osteoblastic cells from dexamethasone. Oncotarget. 2016; 7(43):70613-70622. PMC: 5342578. DOI: 10.18632/oncotarget.12138. View

Wang Y, Jiang T . Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Lett. 2013; 331(2):139-46. DOI: 10.1016/j.canlet.2012.12.024. View

Liu M, Hu C, Xu Q, Chen L, Ma K, Xu N . Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells. Biosci Rep. 2015; 35(5). PMC: 4613709. DOI: 10.1042/BSR20150092. View

Gong Y, Huang W, Li K, Liu Y, Cao G, Cao C . SC79 protects retinal pigment epithelium cells from UV radiation via activating Akt-Nrf2 signaling. Oncotarget. 2016; 7(37):60123-60132. PMC: 5312373. DOI: 10.18632/oncotarget.11164. View

Cao C, Huang X, Han Y, Wan Y, Birnbaumer L, Feng G . Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway. Sci Signal. 2009; 2(68):ra17. PMC: 4138699. DOI: 10.1126/scisignal.2000118. View

Lo H . EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance. Curr Mol Pharmacol. 2009; 3(1):37-52. PMC: 3606625. DOI: 10.2174/1874467211003010037. View

Furman M, Shulman K . Cyclic AMP and adenyl cyclase in brain tumors. J Neurosurg. 1977; 46(4):477-83. DOI: 10.3171/jns.1977.46.4.0477. View

Lefranc F, Rynkowski M, DeWitte O, Kiss R . Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Adv Tech Stand Neurosurg. 2009; 34:3-35. DOI: 10.1007/978-3-211-78741-0_1. View

10.

Bostrom J, Cobbers J, Wolter M, Tabatabai G, Weber R, Lichter P . Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res. 1998; 58(1):29-33. View

11.

Huang A, Ostrowski M, Berard D, Hager G . Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus. Cell. 1981; 27(2 Pt 1):245-55. DOI: 10.1016/0092-8674(81)90408-6. View

12.

Faivre S, Regnauld K, Bruyneel E, Nguyen Q, Mareel M, Emami S . Suppression of cellular invasion by activated G-protein subunits Galphao, Galphai1, Galphai2, and Galphai3 and sequestration of Gbetagamma. Mol Pharmacol. 2001; 60(2):363-72. DOI: 10.1124/mol.60.2.363. View

13.

Zhang Y, Zhang Z, Liu Y, Zhou X, Shi X, Jiang Q . Requirement of Gαi1/3-Gab1 signaling complex for keratinocyte growth factor-induced PI3K-AKT-mTORC1 activation. J Invest Dermatol. 2014; 135(1):181-191. DOI: 10.1038/jid.2014.326. View

14.

Li X, Wu C, Chen N, Gu H, Yen A, Cao L . PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget. 2016; 7(22):33440-50. PMC: 5078108. DOI: 10.18632/oncotarget.7961. View

15.

Li K, Yang S, Gong Y, Yang H, Li X, Zhao Y . 3H-1,2-dithiole-3-thione protects retinal pigment epithelium cells against Ultra-violet radiation via activation of Akt-mTORC1-dependent Nrf2-HO-1 signaling. Sci Rep. 2016; 6:25525. PMC: 4858705. DOI: 10.1038/srep25525. View

16.

Pollack I . Neuro-oncology: Therapeutic benefits of reirradiation for recurrent brain tumors. Nat Rev Neurol. 2010; 6(10):533-5. DOI: 10.1038/nrneurol.2010.144. View

17.

Andradas C, Caffarel M, Perez-Gomez E, Salazar M, Lorente M, Velasco G . The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK. Oncogene. 2010; 30(2):245-52. DOI: 10.1038/onc.2010.402. View

18.

Huang T, Sarkaria S, Cloughesy T, Mischel P . Targeted therapy for malignant glioma patients: lessons learned and the road ahead. Neurotherapeutics. 2009; 6(3):500-12. PMC: 3600166. DOI: 10.1016/j.nurt.2009.04.008. View

19.

Mabuchi S, Altomare D, Cheung M, Zhang L, Poulikakos P, Hensley H . RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model. Clin Cancer Res. 2007; 13(14):4261-70. DOI: 10.1158/1078-0432.CCR-06-2770. View

20.

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View